• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    Alger Russell Innovation Index Updates for First Quarter 2025

    3/17/25 5:28:19 PM ET
    $BIO
    $FMC
    $HPE
    $JNPR
    Biotechnology: Laboratory Analytical Instruments
    Industrials
    Major Chemicals
    Industrials
    Get the next $BIO alert in real time by email

    NEW YORK, March 17, 2025 /PRNewswire/ -- Fred Alger Management, LLC ("Alger"), a privately held growth equity investment manager, today announced the quarterly rebalancing of the Alger Russell Innovation Index ("Index"). Following the close of trading on Friday, March 21, 2025, the Index will be rebalanced, and the following changes will be effective.

    Alger

    Action

    Company Name

    Ticker Symbol

    Addition          

    Bio-Rad Labs A

    BIO                              

    Addition

    FMC Corp

    FMC

    Addition

    Juniper Networks

    JNPR

    Addition

    PayPal Holdings

    PYPL

    Deletion

    Hewlett Packard Enterprise Company

    HPE

    Deletion

    Nutanix, Inc.

    NTNX

    Deletion

    Roblox Corporation

    RBLX

    Deletion

    Solventum Corporation

    SOLV

    For additional information, please visit www.lseg.com. 

    Unlock Your Growth Potential with Alger

    Founded in 1964, Alger is recognized as a pioneer of growth-style investment management. Privately-owned and headquartered in New York City, Alger can help "Unlock Your Growth Potential" through a suite of growth equity separate accounts, mutual funds, ETFs, and privately offered investment vehicles. Alger's investment philosophy, discovering companies undergoing Positive Dynamic Change, has been in place for 60 years. For more information, please visit www.alger.com. 

    Risk Disclosures: Investing in the stock market involves risks, including the potential loss of principal. Growth stocks may be more volatile than other stocks as their prices tend to be higher in relation to their companies' earnings and may be more sensitive to market, political, and economic developments. Local, regional or global events such as environmental or natural disasters, war, terrorism, pandemics, outbreaks of infectious diseases and similar public health threats, recessions, or other events could have a significant impact on investments.

    This material is not meant to provide investment advice and should not be considered a recommendation to purchase or sell securities.

    Alger pays compensation to third party marketers to sell various strategies to prospective investors.

    London Stock Exchange Group plc and its group undertakings (collectively, the "LSE Group"). © LSE Group 2025. FTSE Russell is a trading name of certain of the LSE Group companies. "FTSE®" "Russell®", "FTSE Russell®" are trade marks of the relevant LSE Group companies and are used by any other LSE Group company under license. All rights in the FTSE Russell indexes or data vest in the relevant LSE Group company which owns the index or the data. Neither LSE Group nor its licensors accept any liability for any errors or omissions in the indexes or data and no party may rely on any indexes or data contained in this communication. No further distribution of data from the LSE Group is permitted without the relevant LSE Group company's express written consent. The LSE Group does not promote, sponsor or endorse the content of this communication.

    CONTACTS: 

    Prosek

    Alger

    Sheila Cooney

    203-745-2523

    [email protected]

    Scott A. Anderson

    212-806-2972

     

    Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/alger-russell-innovation-index-updates-for-first-quarter-2025-302403603.html

    SOURCE Alger

    Get the next $BIO alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $BIO
    $FMC
    $HPE
    $JNPR

    CompanyDatePrice TargetRatingAnalyst
    Hewlett Packard Enterprise Company
    $HPE
    6/9/2025$16.00 → $18.00Hold
    Loop Capital
    Solventum Corporation
    $SOLV
    6/6/2025Sector Weight
    KeyBanc Capital Markets
    PayPal Holdings Inc.
    $PYPL
    6/2/2025$68.00Sell
    Truist
    Nutanix Inc.
    $NTNX
    5/20/2025Outperform → Mkt Perform
    Raymond James
    Hewlett Packard Enterprise Company
    $HPE
    5/20/2025$22.00In-line → Outperform
    Evercore ISI
    Solventum Corporation
    $SOLV
    5/19/2025$87.00Neutral → Overweight
    Piper Sandler
    FMC Corporation
    $FMC
    4/25/2025$49.00Neutral → Outperform
    Mizuho
    PayPal Holdings Inc.
    $PYPL
    4/23/2025$56.00Sell
    Compass Point
    More analyst ratings

    $BIO
    $FMC
    $HPE
    $JNPR
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Davidson Carol Anthony bought $223,987 worth of shares (6,000 units at $37.33) (SEC Form 4)

      4 - FMC CORP (0000037785) (Issuer)

      3/6/25 12:07:01 PM ET
      $FMC
      Major Chemicals
      Industrials
    • President, FMC Pereira Ronaldo bought $200,340 worth of shares (5,600 units at $35.77), increasing direct ownership by 13% to 48,837 units (SEC Form 4)

      4 - FMC CORP (0000037785) (Issuer)

      3/5/25 1:43:06 PM ET
      $FMC
      Major Chemicals
      Industrials
    • Chairman and CEO Brondeau Pierre R bought $1,938,449 worth of shares (54,000 units at $35.90), increasing direct ownership by 22% to 298,439 units (SEC Form 4)

      4 - FMC CORP (0000037785) (Issuer)

      3/4/25 3:57:22 PM ET
      $FMC
      Major Chemicals
      Industrials